06/03/2026
🚨Research chemicals should not be showing up on random doorsteps.
That is the uncomfortable truth behind the peptide crackdown.
In this clip from the Decoding Health Podcast, Dr. Urban Kiernan explains why the FDA and DOJ are finally stepping in.
This is not just about peptides.
It is about companies allegedly selling “research use only” compounds directly to people’s homes — without confirming whether those buyers were legitimate researchers, qualified medical professionals, or appropriate business entities.
That creates a serious problem.
Because once these compounds leave controlled professional channels, the risks increase fast:
⚠️ misuse
⚠️ abuse
⚠️ improper dosing
⚠️ unsafe sourcing
⚠️ illegal distribution
⚠️ federal enforcement
The issue is not whether science should move forward.
It should.
The issue is whether companies can hide behind “research use only” language while operating like direct-to-consumer peptide suppliers.
That is why regulators are watching.
That is why companies are being forced to shut down.
And that is why some may face serious legal consequences.
💬 Real question:
Do you think the FDA and DOJ are protecting the public — or limiting access to therapies people are desperately looking for?
👇 Follow for more breakdowns on metabolic health, peptides, biotech, and the future of medicine.
🎥 Watch the full episode on Rumble. 🔗 in first comment.
Proud to acknowledge our strategic partner Unicity International.
Thank you to our sponsors IMetabolic Biopharma Corporation and UK BioScience Consulting, LLC.
Special thanks to our producers at PS Creative & PS Studios.